Gene · 8322
Papers2,273
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,273
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| cRel and Wnt5a/Frizzled 5 Receptor-Mediated Inflammatory Regulation Reveal Novel Neuroprotectin D1 Targets for Neuroprotection. | Cell Mol Neurobiol | 2023 | 35622188 | PubTator, text mining | PubMed |
| Circ_0001971 makes progress of oral squamous cell carcinoma by targeting miR-107/FZD4 axis. | Oral Dis | 2023 | 35403775 | PubTator, text mining | PubMed |
| GPCR Inhibition in Treating Lymphoma. | ACS Med Chem Lett | 2022 | 38239337 | PubTator, text mining | PubMed |
| Phylogeny-wide analysis of G-protein coupled receptors in social amoebas and implications for the evolution of multicellularity. | Open Res Eur | 2022 | 37645274 | PubTator, text mining | PubMed |
| Whole exome sequencing revealed novel pathogenic variants in Vietnamese patients with FEVR. | Mol Vis | 2022 | 37089697 | PubTator, text mining | PubMed |
| Wnt signaling pathway-derived score for predicting therapeutic resistance and tumor microenvironment in lung adenocarcinoma. | Front Pharmacol | 2022 | 36703749 | PubTator, text mining | PubMed |
| Identification of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma. | Front Mol Biosci | 2022 | 36699699 | PubTator, text mining | PubMed |
| CircRNA hsa_circ_0070659 predicts poor prognosis and promotes non-small cell lung cancer (NSCLC) progression via microRNA-377 (miR-377) / Ras-Associated Binding Protein 3C (RAB3C) pathway. | Bioengineered | 2022 | 36694911 | PubTator, text mining | PubMed |
| Cross-species transmission, evolution and zoonotic potential of coronaviruses. | Front Cell Infect Microbiol | 2022 | 36683695 | PubTator, text mining | PubMed |
| Frizzled receptors in melanomagenesis: From molecular interactions to target identification. | Front Oncol | 2022 | 36620565 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Unveils the Dedifferentiation Mechanism of Lung Adenocarcinoma Stem Cells. | Int J Mol Sci | 2022 | 36613925 | PubTator, text mining | PubMed |
| Anti-Obesity Effects of Isorhamnetin and Isorhamnetin Conjugates. | Int J Mol Sci | 2022 | 36613743 | PubTator, text mining | PubMed |
| TLR9 and Glioma: Friends or Foes? | Cells | 2022 | 36611945 | PubTator, text mining | PubMed |
Transcriptional profiling of Hutchinson-Gilford Progeria syndrome fibroblasts reveals deficits in mesenchymal stem cell commitment to differentiation related to early events in endochondral ossification. | Elife | 2022 | 36579892 | PubTator, text mining | PubMed |
| Regulatory role of miRNAs in Wnt signaling pathway linked with cardiovascular diseases. | Curr Res Pharmacol Drug Discov | 2022 | 36568258 | PubTator, text mining | PubMed |
| PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells. | Exp Ther Med | 2022 | 36561964 | PubTator, text mining | PubMed |
| Checkpoint Kinase 1 (CHK1) Functions as Both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal Transition (EMT) in Triple-Negative Breast Cancer. | Curr Issues Mol Biol | 2022 | 36547059 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the Müller subtypes and inner blood-retinal barrier regulatory network in early diabetic retinopathy. | Front Mol Neurosci | 2022 | 36533134 | PubTator, text mining | PubMed |
| The progress and challenges of circRNA for diabetic foot ulcers: A mini-review. | Front Endocrinol (Lausanne) | 2022 | 36531481 | PubTator, text mining | PubMed |
| Pharmacological Activity of Quercetin: An Updated Review. | Evid Based Complement Alternat Med | 2022 | 36506811 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8322/papers?page=18